March 10 (Bloomberg) -- Johnson & Johnson made plans to reach $302 million in geriatric sales for its antipsychotic Risperdal just months after federal regulators...
Elanco, the animal health division of Eli Lilly and Company, announced that Lilly has signed an agreement to acquire the European rights to a portfolio...